Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)

PHASE3

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated by Sponsor as a result of a business decision to discontinue the development program for MK-8342B for reasons unrelated to safety or efficacy.

Conditions

Dysmenorrhea

Interventions

DRUG: ENG 125 μg + E2 300 μg vaginal ring (MK-8342B)
DRUG: Placebo vaginal ring
DRUG: Ibuprofen

Sponsor

Organon and Co